It is not too early to draw lessons from the Covid-19 pandemic, a health emergency that is still affecting the global community. At a meeting of the Sachs Biotech in Europe Forum on 21 September, five pharma executives discussed what has been accomplished thus far, and what still needs to be done to protect against future health crises.
